arcadia

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE1337.801.45 (+0.11 %)
PREV CLOSE ( ) 1336.35
OPEN PRICE ( ) 1360.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2805
TODAY'S LOW / HIGH ( )1332.10 1363.50
52 WK LOW / HIGH ( )1020 1812
NSE1349.805.1 (+0.38 %)
PREV CLOSE( ) 1344.70
OPEN PRICE ( ) 1332.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1349.80 (17)
VOLUME 10271
TODAY'S LOW / HIGH( ) 1332.50 1359.95
52 WK LOW / HIGH ( )1010 1800.05
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 13-11 1924
Management Info
D S Parekh - Chairman A Vaidheesh - Managing Director
Registered Office

Address Dr Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com

Website www.gsk-india.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
22Oct GlaxoSmithKline Pharmaceuticals report
GlaxoSmithKline Pharmaceuticals has reported results for second quarter..
28Sep Glaxosmithkline Pharmaceuticals inform
Glaxosmithkline Pharmaceuticals has informed that in terms of the provis..
28Sep Glaxosmithkline Pharmaceuticals inform
Pursuant to clause 33 of the Listing Obligations and Disclosure requirem..
19Sep Glaxosmithkline Pharmaceuticals inform
Pursuant to the approval granted by the shareholders vide postal ballot..
06Sep Disclosure of Voting results of Posta
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE regarding the detai..
Financials
Rs. in Millions
QTR Sep 18 ANNUAL 18
Net Profit1007.73519.8
Gross Profit 1564.6 5415.8
Operating Profit 1799.85619.6
Net Sales 8163.128958.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Piramal Enterprises (BSE)
 2341.50 (2.26%)
M.Cap ( in Cr)42933.70
Pfizer (BSE)
 2828.80 (1.80%)
M.Cap ( in Cr)12941.12
Merck (BSE)
 3027.35 (1.36%)
M.Cap ( in Cr)5025.21
Ajanta Pharma (BSE)
 1119.65 (3.36%)
M.Cap ( in Cr)9855.50
Divis Lab (BSE)
 1554.45 (1.54%)
M.Cap ( in Cr)41265.76
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 12.62%
FI/BANKS/INSURANCE 8.2%
MUTUAL FUNDS/UTI 2.71%
FII 0%
GOVERNMENT 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM